The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease

被引:3
|
作者
Hu, Yingying [1 ,2 ]
Zhou, Fan [3 ,4 ]
Lei, Fang [2 ,5 ]
Lin, Lijin [1 ,2 ]
Huang, Xuewei [6 ]
Sun, Tao [1 ,2 ]
Liu, Weifang [1 ,2 ]
Zhang, Xingyuan [2 ,5 ]
Cai, Jingjing [2 ,6 ]
She, Zhi-Gang [1 ,2 ]
Li, Hongliang [1 ,2 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
[2] Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China
[3] Yangtze Univ, Huanggang Cent Hosp, Dept Gastroenterol, Huanggang, Peoples R China
[4] Huanggang Inst Translat Med, Huanggang, Peoples R China
[5] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China
[6] Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China
来源
基金
美国国家科学基金会;
关键词
metabolic dysfunction-associated fatty liver disease; thyroid function parameters; nonlinear relationship; restricted cubic spline analysis; multivariable-adjusted logistic regression models; STIMULATES LEPTIN SECRETION; FREE TRIIODOTHYRONINE; ADIPOSE-TISSUE; HORMONE; RISK; NAFLD; HYPOTHYROIDISM; PATHOGENESIS; THYROTROPIN; PREVALENCE;
D O I
10.3389/fendo.2023.1115354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease (MAFLD) remains controversial. Additionally, little is known about the relationship between thyroid function parameters and MAFLD in the Chinese population. MethodsWe conducted a retrospective cross-sectional study involving 177,540 individuals with thyroid function tests and MAFLD diagnosis from 2010-2018. The association between thyroid function parameters and MAFLD was evaluated on a continuous scale with restricted cubic spline (RCS) models and by the prior-defined centile categories with multivariable-adjusted logistic regression models. Thyroid function parameters included free triiodothyronine (FT3), free tetra-iodothyronine (FT4), and thyroid stimulating hormone (TSH). Additionally, fully adjusted RCS models stratified by sex, age, and location were studied. ResultsIn the RCS models, the risk of MAFLD increased with higher levels of FT3 when FT3 <5.58pmol/L, while the risk of MAFLD decreased with higher levels of FT3 when FT3 >= 5.58pmol/L (P nonlinearity <0.05). While RCS analysis suggested that the FT4 levels had a negative association with MAFLD (P nonlinearity <0.05), indicating an increase in FT4 levels was associated with a decreased risk of MAFLD. RCS analysis suggested an overall positive association between the concentration of TSH and MAFLD risk (P nonlinearity <0.05). The rising slope was sharper when the TSH concentration was less than 1.79uIU/mL, which indicated the association between TSH and MAFLD risk was tightly interrelated within this range. The multivariable logistic regression showed that populations in the 81st-95th centile had the highest risk of MAFLD among all centiles of FT3/TSH, with the 1st-5th centile as the reference category. ConclusionsOur study suggested nonlinear relationships between thyroid function parameters and MAFLD. Thyroid function parameters could be additional modifiable risk factors apart from the proven risk factors to steer new avenues regarding MAFLD prevention and treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Low-Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
    Zuarth-Vazquez, Julia
    Moreno-Castaneda, Lidia
    Soriano-Marquez, Juan Pablo
    Velazquez-Aleman, Alain
    Ramos-Ostos, Martha Helena
    Uribe, Misael
    Lopez-Mendez, Ivan
    Juarez-Hernandez, Eva
    LIFE-BASEL, 2023, 13 (04):
  • [12] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [13] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Fan, Hong
    Li, Lili
    Liu, Zhenqiu
    Zhang, Pengyan
    Wu, Sheng
    Han, Xinyu
    Chen, Xingdong
    Suo, Chen
    Cao, Liou
    Zhang, Tiejun
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [14] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Hong Fan
    Lili Li
    Zhenqiu Liu
    Pengyan Zhang
    Sheng Wu
    Xinyu Han
    Xingdong Chen
    Chen Suo
    Liou Cao
    Tiejun Zhang
    BMC Gastroenterology, 23
  • [15] Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer
    Moon, Sang Yi
    Son, Minkook
    Cho, Jung-Hwan
    Kim, Hye In
    Han, Ji Min
    Bae, Ji Cheol
    Suh, Sunghwan
    THYROID, 2025, 35 (01) : 79 - 86
  • [16] The relationship between follicle-stimulating hormone and metabolic dysfunction-associated fatty liver disease in men
    Bin, Dong-Hua
    Liu, Fang
    Peng, Ke-Ping
    Zhan, Min
    Tan, Yan
    Liu, Qiao
    Tang, Wang
    Mo, Zeng-Nan
    Peng, Xiong-Jun
    Tian, Gui-Xiang
    NUTRITION & DIABETES, 2024, 14 (01):
  • [17] Relationship between phthalates exposures and metabolic dysfunction-associated fatty liver disease in United States adults
    Sun, Junhao
    Yang, Siqi
    Zhang, Yue
    Xiang, Wenzhi
    Jiang, Xiubo
    PLOS ONE, 2024, 19 (04):
  • [18] Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment
    Yu, Qiang
    He, Ruixin
    Jiang, Haowen
    Wu, Ji
    Xi, Zhifeng
    He, Kang
    Liu, Yongbo
    Zhou, Tao
    Feng, Mingxuan
    Wan, Ping
    Yan, Hexin
    Xia, Qiang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (06) : 1034 - 1041
  • [19] Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
    Wen, Wen
    Fan, Hua
    Zhang, Shenghui
    Hu, Siqi
    Chen, Chen
    Tang, Jiake
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Dong, Peng
    Zhang, Xingwei
    Wang, Mingwei
    Feng, Yan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (06): : 557 - 568
  • [20] Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective
    Nardolillo, Michele
    Rescigno, Fabiola
    Bartiromo, Mario
    Piatto, Dario
    Guarino, Stefano
    Marzuillo, Pierluigi
    del Giudice, Emanuele Miraglia
    Di Sessa, Anna
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (15) : 2081 - 2086